...
首页> 外文期刊>Bone marrow transplantation >IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
【24h】

IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.

机译:接种肺炎球菌多糖和b型流感嗜血杆菌结合疫苗后,同种异体BMT受体的IgG亚类和针对多糖抗原的抗体的亲和力。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In a randomized study, 20 adult allogeneic BMT recipients were vaccinated at 6 months and 22 at 18 months after BMT with Haemophilus influenzae type b (Hib)-diphtheria toxoid conjugate vaccine (PRP-D), and 23 recipients at 8 months and 21 at 20 months with pneumococcal polysaccharide (Pnc PS) vaccine. IgG1 and IgG2 subclasses of Pnc PS and Hib antibodies and avidities of Pnc PS IgG antibodies were determined by EIA in sera from patients with at least a two-fold total antibody response to Pnc type 3, 6B, 19F or PRP-D. The Pnc PS vaccine induced predominantly IgG1 Pnc 3 antibody production. Anti-Pnc 6B and 19F responses were mainly IgG2. The time of the Pnc PS vaccination, at 8 or 20 months after BMT, did not influence the IgG subclass response pattern. The PRP-D vaccine induced predominantly IgG2 anti-Hib production in the patients vaccinated at 6 months after BMT. The patients vaccinated at 18 months produced IgG1 and IgG2 antibodies more evenly. The same patient was able to produce predominantly IgG1 subclass antibodies to one antigen, Pnc 3, 6B, 19F or Hib, and IgG2 antibodies to another. The avidities of anti-Pnc 6B and 19F 1 month after vaccination were similar to those before vaccination, anti-Pnc 3 avidity was lower than before vaccination but matured in 15 months. The IgG subclass distribution and avidity were similar in the patients with and without chronic GVHD. In conclusion, the IgG response to Pnc type 3 was predominantly IgG1 as in infants and IgG2 to PRP-D, Pnc 6B, and 19F as in adults. Early vaccination after BMT or the presence of chronic GVHD did not impair the quality of response to Pnc PS and PRP-D vaccines.
机译:在一项随机研究中,对20位成年同种异体BMT接受者在BMT后6个月和18个月接受22例乙型流感嗜血杆菌(Hib)-白喉类毒素结合疫苗(PRP-D)的疫苗接种,对23例分别在8个月和21个月接受疫苗接种。肺炎球菌多糖(Pnc PS)疫苗接种20个月。 PEI PS和Hib抗体的IgG1和IgG2亚类以及Pnc PS IgG抗体的亲和力通过EIA在来自对Pnc 3型,6B,19F或PRP-D的总抗体应答至少达到两倍的患者血清中确定。 Pnc PS疫苗主要诱导IgG1 Pnc 3抗体的产生。抗Pnc 6B和19F反应主要是IgG2。 BMT后8或20个月进行Pnc PS疫苗接种的时间不影响IgG亚类应答模式。在BMT后6个月接种疫苗的患者中,PRP-D疫苗主要诱导IgG2抗Hib的产生。在18个月接种疫苗的患者产生的IgG1和IgG2抗体更均匀。同一名患者主要能够产生针对一种抗原Pnc 3、6B,19F或Hib的IgG1亚类抗体,以及针对另一种抗原的IgG2抗体。接种后1个月的抗Pnc 6B和19F亲和力与接种前相似,抗Pnc 3的亲和力低于接种前但在15个月内成熟。有和没有慢性GVHD的患者中IgG亚类分布和亲和力相似。总之,对3型Pnc的IgG反应主要是婴儿的IgG1,对成人PRP-D,Pnc 6B和19F的IgG2。 BMT后早期接种疫苗或存在慢性GVHD不会损害对Pnc PS和PRP-D疫苗的反应质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号